ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs),
Category: Antibody
Hemlibra for treating hemophilia
The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in
Dengue immunity can protect against Zika
Manifestations of Zika virus (ZIKV) infection differ drastically. Sometimes they are catastrophic, most notably when they cause microcephaly in some
Mylotarg for treating acute myeloid leukemia
Mylotarg (gemtuzumab ozogamicin) has been approved for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express
Improved, safer Zika vaccine
Scientists have come up with better plant-based Zika vaccine that is more potent, safer and cheaper. It’s based on key
Antibody against cancer cell
An antibody that can target regulatory T cells which in turn unleashes the immune system to kill cancer cells has
